These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 22764042)

  • 1. MRI versus conventional measures of disease activity and structural damage in evaluating treatment efficacy in juvenile idiopathic arthritis.
    Malattia C; Consolaro A; Pederzoli S; Madeo A; Pistorio A; Mazzoni M; Mattiuz C; Magnano GM; Viola S; Buoncompagni A; Palmisani E; Hasija R; Ruperto N; Ravelli A; Martini A
    Ann Rheum Dis; 2013 Mar; 72(3):363-8. PubMed ID: 22764042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monitoring anti-TNFalpha treatment in rheumatoid arthritis: responsiveness of magnetic resonance imaging and ultrasonography of the dominant wrist joint compared with conventional measures of disease activity and structural damage.
    Haavardsholm EA; Østergaard M; Hammer HB; Bøyesen P; Boonen A; van der Heijde D; Kvien TK
    Ann Rheum Dis; 2009 Oct; 68(10):1572-9. PubMed ID: 19019893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The smallest detectable difference and sensitivity to change of magnetic resonance imaging and radiographic scoring of structural joint damage in rheumatoid arthritis finger, wrist, and toe joints: a comparison of the OMERACT rheumatoid arthritis magnetic resonance imaging score applied to different joint combinations and the Sharp/van der Heijde radiographic score.
    Ejbjerg BJ; Vestergaard A; Jacobsen S; Thomsen HS; Østergaard M
    Arthritis Rheum; 2005 Aug; 52(8):2300-6. PubMed ID: 16052593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. One-year followup study on clinical findings and changes in magnetic resonance imaging-based disease activity scores in juvenile idiopathic arthritis.
    Hemke R; van Veenendaal M; van den Berg JM; Dolman KM; van Rossum MA; Maas M; Kuijpers TW
    J Rheumatol; 2014 Jan; 41(1):119-27. PubMed ID: 24293575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MRI bone oedema is the strongest predictor of subsequent radiographic progression in early rheumatoid arthritis. Results from a 2-year randomised controlled trial (CIMESTRA).
    Hetland ML; Ejbjerg B; Hørslev-Petersen K; Jacobsen S; Vestergaard A; Jurik AG; Stengaard-Pedersen K; Junker P; Lottenburger T; Hansen I; Andersen LS; Tarp U; Skjødt H; Pedersen JK; Majgaard O; Svendsen AJ; Ellingsen T; Lindegaard H; Christensen AF; Vallø J; Torfing T; Narvestad E; Thomsen HS; Ostergaard M;
    Ann Rheum Dis; 2009 Mar; 68(3):384-90. PubMed ID: 18388160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnetic resonance imaging findings in 84 patients with early rheumatoid arthritis: bone marrow oedema predicts erosive progression.
    Haavardsholm EA; Bøyesen P; Østergaard M; Schildvold A; Kvien TK
    Ann Rheum Dis; 2008 Jun; 67(6):794-800. PubMed ID: 17981915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnetic resonance imaging for accelerated assessment of drug effect and prediction of subsequent radiographic progression in rheumatoid arthritis: a study of patients receiving combined anakinra and methotrexate treatment.
    Østergaard M; Duer A; Nielsen H; Johansen JS; Narvestad E; Ejbjerg BJ; Baslund B; Møller JM; Thomsen HS; Petersen J
    Ann Rheum Dis; 2005 Oct; 64(10):1503-6. PubMed ID: 15778238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone oedema predicts erosive progression on wrist MRI in early RA--a 2-yr observational MRI and NC scintigraphy study.
    Palosaari K; Vuotila J; Takalo R; Jartti A; Niemelä RK; Karjalainen A; Haapea M; Soini I; Tervonen O; Hakala M
    Rheumatology (Oxford); 2006 Dec; 45(12):1542-8. PubMed ID: 16670155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiographic progression and remission rates in early rheumatoid arthritis - MRI bone oedema and anti-CCP predicted radiographic progression in the 5-year extension of the double-blind randomised CIMESTRA trial.
    Hetland ML; Stengaard-Pedersen K; Junker P; Østergaard M; Ejbjerg BJ; Jacobsen S; Lottenburger T; Hansen I; Tarp U; Andersen LS; Svendsen A; Pedersen JK; Lauridsen UB; Ellingsen T; Lindegaard H; Pødenphant J; Vestergaard A; Jurik AG; Hørslev-Petersen K;
    Ann Rheum Dis; 2010 Oct; 69(10):1789-95. PubMed ID: 20444751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Magnetic resonance imaging, ultrasonography, and conventional radiography in the assessment of bone erosions in juvenile idiopathic arthritis.
    Malattia C; Damasio MB; Magnaguagno F; Pistorio A; Valle M; Martinoli C; Viola S; Buoncompagni A; Loy A; Ravelli A; Tomà P; Martini A
    Arthritis Rheum; 2008 Dec; 59(12):1764-72. PubMed ID: 19035414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A treat-to-target strategy with methotrexate and intra-articular triamcinolone with or without adalimumab effectively reduces MRI synovitis, osteitis and tenosynovitis and halts structural damage progression in early rheumatoid arthritis: results from the OPERA randomised controlled trial.
    Axelsen MB; Eshed I; Hørslev-Petersen K; Stengaard-Pedersen K; Hetland ML; Møller J; Junker P; Pødenphant J; Schlemmer A; Ellingsen T; Ahlquist P; Lindegaard H; Linauskas A; Dam MY; Hansen I; Horn HC; Ammitzbøll CG; Jørgensen A; Krintel SB; Raun J; Krogh NS; Johansen JS; Østergaard M;
    Ann Rheum Dis; 2015 May; 74(5):867-75. PubMed ID: 24412895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiographic damage in hands and wrists of patients with juvenile idiopathic arthritis after 29 years of disease duration.
    Selvaag AM; Kirkhus E; Törnqvist L; Lilleby V; Aulie HA; Flatø B
    Pediatr Rheumatol Online J; 2017 Apr; 15(1):20. PubMed ID: 28399930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. No overall damage progression despite persistent inflammation in adalimumab-treated psoriatic arthritis patients: results from an investigator-initiated 48-week comparative magnetic resonance imaging, computed tomography and radiography trial.
    Poggenborg RP; Wiell C; Bøyesen P; Boonen A; Bird P; Pedersen SJ; Sørensen IJ; Madsen OR; Slot O; Møller JM; Hasselquist M; Kubassova O; Østergaard M
    Rheumatology (Oxford); 2014 Apr; 53(4):746-56. PubMed ID: 24369412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tocilizumab may slow radiographic progression in patients with systemic or polyarticular-course juvenile idiopathic arthritis: post hoc radiographic analysis from two randomized controlled trials.
    Malattia C; Ruperto N; Pederzoli S; Palmisani E; Pistorio A; Wouters C; Dolezalova P; Flato B; Garay S; Giancane G; Wells C; Douglass W; Brunner HI; De Benedetti F; Ravelli A;
    Arthritis Res Ther; 2020 Sep; 22(1):211. PubMed ID: 32912276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bilateral evaluation of the hand and wrist in untreated early inflammatory arthritis: a comparative study of ultrasonography and magnetic resonance imaging.
    Navalho M; Resende C; Rodrigues AM; Pereira da Silva JA; Fonseca JE; Campos J; Canhão H
    J Rheumatol; 2013 Aug; 40(8):1282-92. PubMed ID: 23729806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selecting magnetic resonance imaging (MRI) outcome measures for juvenile idiopathic arthritis (JIA) clinical trials: first report of the MRI in JIA special interest group.
    Hemke R; Doria AS; Tzaribachev N; Maas M; van der Heijde DM; van Rossum MA
    J Rheumatol; 2014 Feb; 41(2):354-8. PubMed ID: 24187109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence of radiographic benefit of treatment with infliximab plus methotrexate in rheumatoid arthritis patients who had no clinical improvement: a detailed subanalysis of data from the anti-tumor necrosis factor trial in rheumatoid arthritis with concomitant therapy study.
    Smolen JS; Han C; Bala M; Maini RN; Kalden JR; van der Heijde D; Breedveld FC; Furst DE; Lipsky PE;
    Arthritis Rheum; 2005 Apr; 52(4):1020-30. PubMed ID: 15818697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced joint assessment vs comprehensive assessment for ultrasound detection of synovitis in juvenile idiopathic arthritis.
    Collado P; Naredo E; Calvo C; Gamir ML; Calvo I; García ML; Merino R; Graña J; Bustabab S; Garrido J;
    Rheumatology (Oxford); 2013 Aug; 52(8):1477-84. PubMed ID: 23620551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Presence of significant synovitis in rheumatoid arthritis patients with disease-modifying antirheumatic drug-induced clinical remission: evidence from an imaging study may explain structural progression.
    Brown AK; Quinn MA; Karim Z; Conaghan PG; Peterfy CG; Hensor E; Wakefield RJ; O'Connor PJ; Emery P
    Arthritis Rheum; 2006 Dec; 54(12):3761-73. PubMed ID: 17133543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors associated with treatment response to etanercept in juvenile idiopathic arthritis.
    Otten MH; Prince FH; Armbrust W; ten Cate R; Hoppenreijs EP; Twilt M; Koopman-Keemink Y; Gorter SL; Dolman KM; Swart JF; van den Berg JM; Wulffraat NM; van Rossum MA; van Suijlekom-Smit LW
    JAMA; 2011 Dec; 306(21):2340-7. PubMed ID: 22056397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.